Targeted Market Medical devices focused on migraine treatment via sTMS position the company in neurology and pain management markets. Potential upsell opportunities include expanding physician adoption in headache centers, clinics, and hospital systems that manage chronic migraine patients.

Strategic Partnerships Near-term growth opportunities exist with healthcare providers, medtech distributors, and specialty clinics that can streamline procurement of portable sTMS devices. Engage via KOLs and headaches specialists to accelerate clinical adoption and reimbursement discussions.

Expansion Readiness Recent office consolidations and manufacturing shifts suggest readiness to scale operations. Sales outreach can target medical device distributors and service partners in regions where the company has established logistics capabilities.

Financial Leverage Funding level indicates strong investor backing for growth. Position capital-efficient deployments, warranty and service plans, and favorable ROI narratives to health systems evaluating TMS-based migraine solutions.

Technology Infrastructure Tech stack with cloud and e-commerce platforms suggests potential for digital trial programs, remote monitoring, and customer self-service portals. Offer value through digital onboarding, training, and post-sale support to drive user adoption and satisfaction.